Tocilizumab linked to 45% lower risk of dying among critically ill COVID-19 patients

Critically ill COVID-19 patients who received a single dose of a drug that calms an overreacting immune system were 45% less likely to die overall, and more likely to be out of the hospital or off a ventilator one month after treatment, compared with those who didn't receive the drug, according to a new study [...]

The post Tocilizumab linked to 45% lower risk of dying among critically ill COVID-19 patients appeared first on Outbreak News Today.